SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
295I know I'm just whining, but Arql is starting to creep me out. There is inkeokalani'nui-7/28/2006
294Mike, don't you think that when a trend(such as biotech experienced recentlyzeta1961-7/12/2006
293With no news in the past several weeks, you cant beat yourself up too much for mMike McFarland-7/12/2006
292<i><40% in just a few weeks would get a person out of a rut></i&gzeta1961-7/12/2006
291Arqule was deleted from the Russell 3000 russell.com ...and has rebounded sharpMike McFarland-7/12/2006
290Arqule at $4 is as low as the shares have been since fall 2004. finance.yahoo.cMike McFarland-6/26/2006
289ArQule Initiates Phase 2 Clinical Development of ARQ 501 for Pancreatic Cancer Ian@SI-6/20/2006
288Thanks, your points make good sense. My focus was on apparent safety and the enIan@SI-6/15/2006
287The monotherapy trials are small markets. The combo trials are in markets thakeokalani'nui-6/15/2006
286Wilder, As I read the PR, it sounded quite encouraging that, just maybe, ARQL hIan@SI-6/15/2006
285Not sure this is enough to hold Roche's interest. Stock price says probablykeokalani'nui-6/15/2006
284Too many holes in that PR to make much out of it.keokalani'nui-6/2/2006
283I guess I could be charitable and suggest that Cunningham is saving it for ASCO,Ian@SI-6/2/2006
282As usual, Hill had plenty to say. But what did Dr. Cunningham have to say? Thescaram(o)uche-6/2/2006
281ASCO Publication Highlights Promising Data from ArQule's Phase I CombinationIan@SI-6/2/2006
280ArQule Reports First Quarter 2006 Financial Results Thursday April 27, 7:00 am Emopgcw-4/27/2006
279from proxy: <pre> Barclays 2,399,376 6.80% Black Bear 2,789,556 7.90% mopgcw-4/25/2006
278ArQule Announces Receipt of Milestone Payment from Wyeth Tuesday April 18, 7:00 mopgcw-4/18/2006
277WOBURN, Mass.--(BUSINESS WIRE)--April 4, 2006--ArQule, Inc. (Nasdaq: ARQL - Newstom pope-4/4/2006
276Someone sure liked it by the end of the day: <http://finance.yahoo.com/q/bc?sD.Lu-3/31/2006
275Tuck thanks you. Does lapachone lack, uh, cohones?keokalani'nui-3/31/2006
274Abstract Number: LB-142 Presentation Title: Phase I trial of ARQ 501, a novel cscaram(o)uche-3/31/2006
273I understand the late breaker abstracts are to be posted tomorrow. I'll be tuck-3/30/2006
272It's a poster presentation....and it's not asco.keokalani'nui-3/30/2006
271FINALLY! Does late breaking session mean no one will be there? :) Jailbreak? atticus4paws-3/30/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News